CA2313230A1 - Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) - Google Patents

Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) Download PDF

Info

Publication number
CA2313230A1
CA2313230A1 CA002313230A CA2313230A CA2313230A1 CA 2313230 A1 CA2313230 A1 CA 2313230A1 CA 002313230 A CA002313230 A CA 002313230A CA 2313230 A CA2313230 A CA 2313230A CA 2313230 A1 CA2313230 A1 CA 2313230A1
Authority
CA
Canada
Prior art keywords
ramatroban
thermodynamically stable
modification
mod
stable modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002313230A
Other languages
English (en)
French (fr)
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Yakuhin Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2313230A1 publication Critical patent/CA2313230A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002313230A 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) Abandoned CA2313230A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
DE19757983.3 1997-12-24
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (1)

Publication Number Publication Date
CA2313230A1 true CA2313230A1 (en) 1999-07-08

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002313230A Abandoned CA2313230A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (instruction)
EP (1) EP1051398B1 (instruction)
JP (2) JP3817668B2 (instruction)
KR (1) KR100586350B1 (instruction)
CN (1) CN1140510C (instruction)
AR (1) AR013803A1 (instruction)
AT (1) ATE263152T1 (instruction)
AU (1) AU744242B2 (instruction)
BG (1) BG65024B1 (instruction)
BR (1) BR9814496A (instruction)
CA (1) CA2313230A1 (instruction)
CO (1) CO4970800A1 (instruction)
DE (2) DE19757983A1 (instruction)
DK (1) DK1051398T3 (instruction)
ES (1) ES2218874T3 (instruction)
GT (1) GT199800198A (instruction)
HN (1) HN1998000186A (instruction)
HU (1) HUP0004432A3 (instruction)
ID (1) ID25446A (instruction)
IL (1) IL136278A (instruction)
IN (1) IN192932B (instruction)
MY (1) MY116312A (instruction)
NO (1) NO316618B1 (instruction)
NZ (1) NZ504741A (instruction)
PE (1) PE20000115A1 (instruction)
PL (1) PL341359A1 (instruction)
PT (1) PT1051398E (instruction)
RU (1) RU2220137C2 (instruction)
SI (1) SI1051398T1 (instruction)
SK (1) SK285109B6 (instruction)
TR (1) TR200001936T2 (instruction)
TW (1) TW552258B (instruction)
UA (1) UA66832C2 (instruction)
UY (2) UY25324A1 (instruction)
WO (1) WO1999033803A1 (instruction)
ZA (1) ZA9811817B (instruction)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
US20100099693A1 (en) * 2007-01-16 2010-04-22 Johan Raud New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
WO2016128565A1 (en) 2015-02-13 2016-08-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
ES2218874T3 (es) 2004-11-16
HK1034517A1 (en) 2001-10-26
RU2220137C2 (ru) 2003-12-27
IL136278A (en) 2005-03-20
PL341359A1 (en) 2001-04-09
BG65024B1 (bg) 2006-12-29
UY25324A1 (es) 2000-12-29
CN1140510C (zh) 2004-03-03
TR200001936T2 (tr) 2001-01-22
GT199800198A (es) 1998-12-15
WO1999033803A1 (en) 1999-07-08
EP1051398B1 (en) 2004-03-31
US6362214B1 (en) 2002-03-26
EP1051398A1 (en) 2000-11-15
NZ504741A (en) 2002-10-25
ATE263152T1 (de) 2004-04-15
HN1998000186A (es) 1999-11-03
UY25575A1 (es) 1999-11-17
IL136278A0 (en) 2001-05-20
JP4411269B2 (ja) 2010-02-10
BG104554A (en) 2001-05-31
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
DE19757983A1 (de) 1999-07-01
SI1051398T1 (en) 2004-08-31
TW552258B (en) 2003-09-11
KR20010033529A (ko) 2001-04-25
IN192932B (instruction) 2004-06-12
JP2006151977A (ja) 2006-06-15
JP3817668B2 (ja) 2006-09-06
NO20003217L (no) 2000-06-21
BR9814496A (pt) 2000-10-10
UA66832C2 (uk) 2004-06-15
HUP0004432A2 (hu) 2001-06-28
HUP0004432A3 (en) 2002-10-28
NO316618B1 (no) 2004-03-08
AU744242B2 (en) 2002-02-21
CO4970800A1 (es) 2000-11-07
ID25446A (id) 2000-10-05
PE20000115A1 (es) 2000-03-26
JP2001527067A (ja) 2001-12-25
DE69822882D1 (en) 2004-05-06
CN1282320A (zh) 2001-01-31
DK1051398T3 (da) 2004-07-19
SK9752000A3 (en) 2001-02-12
MY116312A (en) 2003-12-31
AU1687499A (en) 1999-07-19
PT1051398E (pt) 2004-07-30
ZA9811817B (en) 1999-06-29
AR013803A1 (es) 2001-01-10
NO20003217D0 (no) 2000-06-21
DE69822882T2 (de) 2005-02-03

Similar Documents

Publication Publication Date Title
US20020035130A1 (en) Novel compound
EP2350009B1 (en) Sulfonate salts of flupirtine
JP2003528100A (ja) カベルゴリンの結晶性形態ｉを調製するための方法
CA2993134A1 (en) Crystalline forms of bilastine and preparation methods thereof
US20060079706A1 (en) Bicalutamide polymorphs
CA2313230A1 (en) Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)
EP0703915B1 (en) Xamoneline tartrate
CA2464961A1 (en) Polymorphous forms of rosiglitazone maleate
KR20010042552A (ko) 파록세틴 말레에이트
CZ21498A3 (cs) Izolovaná krystalická forma anhydrátu 7-[(7-(S)-amino-5-azaspiro[2.4]heptan-5-yl]-8-chlor-6-fluor-1-[(1R,2S)-2-fluor-cyklopropyl]-4-oxo-1,4-dihydrochinolin-3-karboxylové kyseliny a antibakteriální farmaceutický prostředek
MXPA00005858A (en) Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino]-1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)
CZ281999B6 (cs) Fyzikální forma (R)-3-methoxy-4-/1-methyl-5-(2 methyl-4,4,4-trifluorbutylkarbamoyl)indol-3 ylmethyl/-N-(2-methylfenylsulfonyl)benzamidu
US20040038985A1 (en) Crystal forms of 1- [6-chloro-5-(trifluoromethly) -2-pyridinyl] piperazine hydrochloride
US20040186100A1 (en) Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
CZ20002325A3 (cs) Termodynamicky stabilní modifikace I ramatrobanu, způsob její výroby a její použití
HK1034517B (en) Thermodynamically stable form of (r)-3-((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban)
WO2025083656A1 (en) Novel crystalline form of lenacapavir sodium and processes for its preparation
CA2496684A1 (en) Crystalline solid famciclovir forms i, ii, iii and preparation thereof
DE102004044555A1 (de) Thermodynamisch stabile Form von (2S)-2-((1S)-5-{2-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]ethoxy}-2,3-dihydro-1H-inden-1-yl)buttersäure

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued